- idUS
- Browsing by Author
Browsing by Author "Marín, Francisco"
Now showing items 1-3 of 3
-
Article
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program
López-Sendón, José L.; Alonso-Rodríguez, David; Barón-Esquivias, Gonzalo; Cosin-Sales, Juan; Marín, Francisco; Galera-Llorca, Jordi; Jiménez, Natalia; Marler, Sabrina; Huisman, Menno V. (Elsevier España, 2022)Background and objective Thromboembolic risk is higher in women than men with non-valvular atrial fibrillation (NVAF). ...
-
Article
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study
Sánchez, Manuel Anguita; Marín, Francisco; Masjuan, Jaime; Cosín-Sales, Juan; Vázquez Rodríguez, José Manuel; Barrios, Vivencio; Barón-Esquivias, Gonzalo; Fernández, Marcelo Sanmartín (Via Medica, 2022)Background: The aim of this study was to analyze the impact of the presence of heart failure (HF) on the clinical profile ...
-
Article
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study
Sanmartín Fernández, Marcelo; Anguita Sánchez, Manuel; Arribas, Fernando; Barón-Esquivias, Gonzalo; Barrios, Vivencio; Cosin-Sales, Juan; Marín, Francisco (Via Medica, 2022)atrial fibrillation (AF) treated with rivaroxaban and to improve the accuracy of 2MACE. Methods: This was a post-authorization ...